Effective January 24, 2022, the FDA updated the Emergency Use Authorization (EUA) fact sheets for two COVID-19 monoclonal antibody treatments: bamlanivimab plus etesevimab (Eli Lilly) and casirivimab plus imdevimab (Regeneron, also known as REGEN-COV). Neither of these treatments are authorized for use anywhere in the U.S. due to their ineffectiveness against the dominant Omicron variant. Sites are directed to immediately stop administering these therapeutics as they do not retain EUA.

Ph: (443) 281-9157

Fax: (410) 582-8728

801 Landmark Dr.
Glen Burnie, MD 21061
Contact Us

Mon-Fri: 8:30AM-6:30PM

Sat: 9:00AM-2:00PM

Medicare Enrollment

FREE Consultation

Every year, Medicare Advantage and Part D plans change their costs, benefits, and/or rules for the upcoming year. Even if you’re satisfied with your current Medicare coverage, schedule a consultation at Soleil Pharmacy to check to see if there is another plan in your area that might offer better health and/or drug coverage at a more affordable price.

Add to your appointment:
□ Influenza/Flu vaccine

medicare entrollment now open
    Your Cart
    Your cart is emptyReturn to Shop